| Nelly Gonzalez, MD | |
|
7617 Little River Tpk, Suite 600, Annandale, VA 22003 | |
| (703) 256-5680 | |
| (703) 658-1684 |
| Full Name | Nelly Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 7617 Little River Tpk, Annandale, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053352997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101222098 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Physician Partners Llc | 2466581772 | 300 |
News Archive
The Alzheimer's Biomarkers Consortium - Down Syndrome, a multi-institution research team, co-led by members from the University of California, Irvine, has been awarded an unprecedented five-year, $109 million grant by the National Institutes of Health, to expand research on the biomarkers of Alzheimer's disease in adults with Down syndrome.
Hispanics adults hospitalized for treatment of symptoms of peripheral artery disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes (QCOR) Research Scientific Sessions 2021.
Scientists have measured the interaction of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein with nano-gold colloids. These nanoparticles functionalized with the S protein have different spectroscopic signals allowing for new information about the protein to be extracted.
A new $2.4-million program for graduate students seeking to contribute to breakthrough discoveries in medicine and biology has been established at Penn State University with nearly $1.4 million in funding from the National Library of Medicine of the U.S. National Institutes of Health and more than $1 million from Penn State.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 2 days ago
| Entity Name | Inova Physician Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215264916 PECOS PAC ID: 2466581772 Enrollment ID: O20100525000846 |
News Archive
The Alzheimer's Biomarkers Consortium - Down Syndrome, a multi-institution research team, co-led by members from the University of California, Irvine, has been awarded an unprecedented five-year, $109 million grant by the National Institutes of Health, to expand research on the biomarkers of Alzheimer's disease in adults with Down syndrome.
Hispanics adults hospitalized for treatment of symptoms of peripheral artery disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes (QCOR) Research Scientific Sessions 2021.
Scientists have measured the interaction of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein with nano-gold colloids. These nanoparticles functionalized with the S protein have different spectroscopic signals allowing for new information about the protein to be extracted.
A new $2.4-million program for graduate students seeking to contribute to breakthrough discoveries in medicine and biology has been established at Penn State University with nearly $1.4 million in funding from the National Library of Medicine of the U.S. National Institutes of Health and more than $1 million from Penn State.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nelly Gonzalez, MD 7617 Little River Turnpike, Suite 600, Annandale, VA 22003 Ph: (703) 256-5680 | Nelly Gonzalez, MD 7617 Little River Tpk, Suite 600, Annandale, VA 22003 Ph: (703) 256-5680 |
News Archive
The Alzheimer's Biomarkers Consortium - Down Syndrome, a multi-institution research team, co-led by members from the University of California, Irvine, has been awarded an unprecedented five-year, $109 million grant by the National Institutes of Health, to expand research on the biomarkers of Alzheimer's disease in adults with Down syndrome.
Hispanics adults hospitalized for treatment of symptoms of peripheral artery disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes (QCOR) Research Scientific Sessions 2021.
Scientists have measured the interaction of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein with nano-gold colloids. These nanoparticles functionalized with the S protein have different spectroscopic signals allowing for new information about the protein to be extracted.
A new $2.4-million program for graduate students seeking to contribute to breakthrough discoveries in medicine and biology has been established at Penn State University with nearly $1.4 million in funding from the National Library of Medicine of the U.S. National Institutes of Health and more than $1 million from Penn State.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 2 days ago
Van-anh Thi Nguyen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7432 Little River Tpke, Annandale, VA 22003 Phone: 703-658-7060 Fax: 703-658-3150 | |
Seetha M Durbhakula, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7617 Little River Turnpike, Suite 600, Annandale, VA 22003 Phone: 703-256-5680 Fax: 703-658-1684 | |
Dr. Mark George Janczewski, MD, MPH Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3438 Holly Rd, Annandale, VA 22003 Phone: 703-698-5811 | |
Alexis Sienna Halyard, Family Medicine Medicare: Medicare Enrolled Practice Location: 7617 Little River Tpke Ste 850, Annandale, VA 22003 Phone: 571-665-6636 | |
Dr. Annick Stam-cheatham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7617 Little River Tpke Ste 710, Annandale, VA 22003 Phone: 703-941-0267 Fax: 703-941-2018 | |
Dr. Mercedes Quintos-gomez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7617 Little River Tpke, Ste 710, Annandale, VA 22003 Phone: 703-941-1732 Fax: 703-941-2018 |